Biopharma News : Biopharma and Pharma news from all around the world :
- Covalon Announces Conference Call to Discuss First Quarter Financial Results
- Pharma E-Commerce Market in Europe 2020-2024 | Availability of Internet Providing Convenience to Consumers to Boost Growth | Technavio
- NantHealth Reports 2019 Fourth-quarter, Full-year Financial Results
- Baron & Budd Obtains $11,850,000 Settlement in False Claims Act Case Against Sanofi-Aventis U.S., LLC
- L2P Research, LLC Announces Acquisition
- Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants
- Nanobiotix 2019 Q4 and Annual Revenues
- SpendEdge Helped A Fortune 500 Global Pharmaceutical Company Develop a Successful Commodity Procurement Strategy and Realize Savings of $3 Million in Supplier Negotiations | Request a Free Proposal to Gain Details Insights
- Global Artificial Blood Vessels Market (2020 to 2025) – Featuring Humacyte, Jotec GmbH, LeMaitre Vascular Among Others – ResearchAndMarkets.com
- Loyola University Chicago Launches Annual Innovator in Social Business Awards
- Horizon and Willis Tower Elevate the Need for Rare Disease Innovation on Rare Disease Day
- 2020 LifeSciences BC Annual Award Winners Announced
- Puma Biotechnology to Present at Cowen’s Annual Health Care Conference
- Lattice Biologics Ltd. Reports Q1 2020 Results
- Compass Therapeutics to Present at the 40th Cowen Health Care Conference
- Agilent Technologies Announces Webcasts for Investment Community
- Respivant Sciences Supports International Rare Disease Day Through Awareness Activities
- Horizon Therapeutics plc Partners with EveryLife Foundation to Establish $1 Million #RAREis Scholarship for Adults with Rare Diseases
- Stimwave and Nevro Reach Settlement In Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction in Exchange for Dismissal of Lawsuit with No Damages Assessed
- LabVantage Solutions Announces SaaS Option for Its Industry-Leading LIMS Platform
- Ra Pharmaceuticals Supports 13th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases
- Antibe Therapeutics Announces Enrollment of Last Patient in Phase 2B Dose-ranging, Efficacy Study of Lead Drug, ATB-346
- Sangamo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
- Harbour BioMed Announces U.S. FDA Approval of IND for Its Next Generation anti-CTLA-4 Antibody, HBM4003, to Treat Cancer
- Verastem Oncology Announces $100 Million Private Placement Offering of Common Stock to Premier Life Sciences Investors
- Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market, 2019-2030 – ResearchAndMarkets.com
- With Topline Growth of 7% in 2019, Margin Improvements and Pipeline Success, LEO Pharma Paves the Way for an Ambitious Future
- PerkinElmer Collaborates with Public Health England on SCID Screening Evaluation Initiative
- Celprogen Awarded ISO 9001-2015 Certification
- Appili Therapeutics Reports Financial and Operational Results for Third Quarter Fiscal Year 2020
Biotech – Biopharma News!
- Centers for Medicare & Medicaid Services open NCD review process for Epi proColon
- Asklepios and RHÖN-KLINIKUM founder join forces: Agreement on joint venture and takeover offer for RHÖN-KLINIKUM AG
- B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG is starting the 2019/20 financial year with a successful quarter
- AEVIS VICTORIA SA: total turnover jumps by 41.1% to CHF 927.5 million in 2019
- B.R.A.I.N. Biotechnology Research And Information Network AG: Resignation of the member of the Supervisory Board Dr. Marquart
- ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD Biotechnologies AG:
- Abivax Includes First Patient in U.S. Phase 1/2 Clinical Trial of ABX196 to Treat Hepatocellular Carcinoma
- Biotest AG: Biotest exceeds already raised EBIT guidance
- MediClin AG: Group sales increased by 4,3 % up to EUR 673.1 mill. – preliminary Group-EBIT amounts to EUR 22.4 mill.
- Biofrontera AG: Biofrontera AG resolves to issue qualified subordinated mandatory convertible bonds
- APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China
- Eckert & Ziegler: Earnings per Share Rise to EUR 4.29 According to Preliminary Figures
- Securecell AG: Securecell partners with Alit Life Science, Biofors Global Inc. and Danyel Biotech as Marketing & Sales Partners in China, South Korea and Israel
- Heidelberg Pharma AG: Partner Magenta Therapeutics Presents Preclinical Data on Lead Clinical Candidate MGTA-117 Demonstrating Broad Tolerability and High Therapeutic Index
- curasan AG: Filing of application for insolvency proceedings
- Adrenomed Announces Positive Top-Line AdrenOSS-2 Phase II Results with Adrecizumab in Septic Shock
- 4basebio AG: 4basebio AG announces allotment ratio and final number of shares for the share buy back
- Fresenius Medical Care published form 20-F for the fiscal year 2019
- RHÖN-KLINIKUM AG Increases Revenues by 5.8 Percent to Euro 1.3 billion Pursuant to Preliminary Figures – Operative Challenges in 2019
- Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline
- Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
- HumanOptics AG: CE-marking for innovative trifocal lens TRIVA(R)
- Dermapharm Holding SE to acquire Allergopharma
- Dermapharm Holding SE: Acquisition of Allergopharma
- Biofrontera AG: Biofrontera provides clinical development updates
- Gerresheimer AG: Gerresheimer sets foundation for profitable growth in 2019
- Douglas sales hit record high again during the Christmas quarter
- Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia
- 4basebio AG: 4basebio AG announces results of the public share buyback offerand final purchase price for the share buy back (news with additional features)
- Xlife Sciences AG: Capital Increase ‘Private Placement’
- CENTOGENE Marks Rare Disease Day 2020 With a Global Line up of Events
- Dentsply Sirona Declares Quarterly Cash Dividend
- Hemostemix Announces Corporate Update
- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- IRIDEX to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
- Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter 2019 Financial Results on March 5, 2020
- Ozop Surgical Corp. Announces Binding Letter of Intent With Power Conversion Technologies, Inc.
- Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
- ICU Medical, Inc. to Present at the Raymond James 41st Annual Institutional Investors Conference
- Only 16% of US Physicians Believe the US Government is Taking Strong Precautions to Prevent the Spread of the Coronavirus, According to Wave 2 of InCrowd’s COVID-19 Tracking Report
- American BriVision Provides Corporate Update
- Olainfarm Group’s net profit in 2019 increased by 156% and exceeded 27 million EUR; reviewed commercial processes will improve sales of products in the main markets
- Hobo Cannabis Company Cements Expansion into Prairies with Lethbridge Store Opening
- Bio-Path Holdings to Announce Fourth Quarter and Full Year 2019 Financial Results on March 6, 2020
- Morphic Therapeutic to Present at the 40th Annual Cowen Health Care Conference
- Intercept to Present at the Cowen 40th Annual Health Care Conference
- Molecular Templates to Present at Three March Investor Conferences
- Retrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care
- NEXSTIM PLC FINANCIAL STATEMENTS RELEASE 2019
- On “Grindeks” results in 2019
- Orphazyme announces Annual Report 2019
- Vistin Pharma ASA: Change in oil derivative exposure
- Vistin Pharma ASA: Fourth quarter 2019 financial results
- Novan Announces Pricing of $5.5 Million Public Offering
- Covetrus Announces Fourth Quarter and Full Year 2019 Earnings Release Date and Conference Call Information
- Passage Bio Announces Pricing of Initial Public Offering
- BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual Meeting
- Sonoma Pharmaceuticals Announces Asset Purchase Agreement with Middle East Partner MicroSafe Group
- Extendicare Announces Fourth Quarter and Year End 2019 Results
- HIMSS20 Proceeds as Scheduled
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News